Lilian Njagi, cohort 9, graduate from the University of Nairobi, attended the second EU-Africa PerMed summer school that took place from May 21-23, 2024, at the KCB Leadership Centre in Nairobi, Kenya. During the workshop, she presented on ‘HIV and TB under a Personalised Medicine point of view’, where she shed light on the burden and current management of TB and HIV in Kenya, including TB preventive therapy. This treatment targets high-risk populations with HIV, diabetes, and household contacts. “What is needed is having a mixed workshop where policymakers and big funders hear presentations like yours to convince them that it is not only non-communicable diseases but also communicable diseases that need funding for personalized medicine, and so we might contact you if we have the opportunity to one of our policy-oriented workshops because your presentation was very clear,” said Erika Sela the EU-Africa PerMed coordinator. Lilian is a Clinical Research Scientist at the Kenya Medical Research Institute (KEMRI), Centre for Respiratory Disease Research, with interests in Tuberculosis/HIV co-infection research looking at novel solutions to monitoring the treatment of latent TB to improve outcomes, including assessing the role of immune response and pharmacogenetics.
